The company expects data from phase II study by late 2015 or early 2016 depending on the design of the phase II study.
here is the link: remember THLD from $1 to $10 and now sitting at $4 range after a $500 mill partnership agreement from Merck extremely big news.
Nice try shorty
I am not short but keep in mind that the company has already lost on excess of $95,000,000 and not even a chance of a profit for at least 2-years. You might have better luck with a lottery ticket.
Sentiment: Strong Sell
Not a try-its the truh!